HERBS FOR HEALTH MANAGEMENT

Herbs are a foundational root in medicine and health treatments, dating back thousands of years throughout every culture around the world. Modern Western herbalism comes from ancient Egypt. The Greeks developed a comprehensive philosophy of herbal medicine by 100 BCE and the Romans built upon it to create a variety of medical practices, some of which are still used today.

….FULL ARTICLE

ALTERNATIVE MEDICINE IMPACTS PSYCHOLOGICAL HARDINESS

Psychological hardiness is an individual’s resistance to stress, anxiety and depression. It includes the ability to withstand grief and accept the loss of loved ones. Alternative medicine is a more popular term for health and wellness therapies that have typically not been part of conventional Western medical approaches but are often used along with conventional medicinal protocols.  Coping and dealing with stress in a positive manner play a major role in maintaining the balance needed for health and well-being.

….FULL ARTICLE

ALTERNATIVE REMEDIES FOR ANXIETY AND DEPRESSION

Interest in complimentary and alternative medicine (CAM) is increasing as consumers and health care professionals search for additional ways to treat anxiety, depression and other mental health disorders. Some of these remedies include:

St. John’s Wort.  More than 30 studies show it to be effective for treatment of mild forms of depression,…

….FULL ARTICLE

Use the buttons below to scroll through more great articles on health and wellness issues

MORE ARTICLES

Be Sociable, Share!

Share on Facebook Share on Twitter Share on Delicious Share on Digg Share on Google Bookmarks Share on LinkedIn Share on LiveJournal Share on Newsvine Share on Reddit Share on Stumble Upon Share on Tumblr

MORE FEATURE ARTICLES

CONTACT INFORMATION

© Health & Wellness Magazine - All rights reserved | Designed and Maintained by Aurora Automations LLC.

MORE FROM ROCKPOINT PUBLISHING

HEALTH & WELLNESS MAGAZINE

HOME | FEATURE ARTICLES | COLUMNS | DIGITAL ISSUES | CALENDAR | RACE RUNNING CALENDAR | ABOUT | CONTACT

subscribe to Health & Wellness


without the usual terror and panic. “I was able to find such empathy for myself,” she said. More than a year after undergoing MDMA-assisted psychotherapy, Tipton no longer qualifies as having PTSD.


“MDMA allows you to contact feelings and sensations in a much more direct way,” said Saj Razvi, a Colorado-based psychotherapist who was a clinical investigator in the Phase 2 trials. “Trauma happens in isolation. One of the things MDMA does is it lets you know you are not alone.”


Sources  


PHYCHEDELICS IN THERAPY

ANGELA S. HOOVER





Angela is a staff writer for Health & Wellness magazine.

as Ecstasy. In laboratory studies, pure MDMA has been proven sufficiently safe for human consumption when taken a limited number of times in moderate doses.


MDMA was first synthesized in 1912. Its therapeutic benefits were studied in the 1970s. Those efforts stalled when the U.S. federal government designated it as a Schedule I drug in 1985 due to its growing popularity as a recreational drug. Schedule I controlled substances are considered to have no accepted medical use and have a high potential for abuse, a claim MDMA therapeutic proponents dispute.


After Phase 2 trials of MDMA-assisted PAP treatments concluded in 2017, researchers found 54 percent of the 72 patients who took MDMA had improved to the point that they no longer fit the diagnosis for PTSD. The beneficial effects of the treatment appeared to increase over time. A year later, the number of patients who no longer had PTSD had risen to 68 percent. The remaining third had less intense symptoms. The improvements lasted up to four years, mostly without additional treatments and without inducing drug abuse or dependence. Lori Tipton, a participant in one of the Phase 2 trials, said in the embrace of MDMA, she could revisit a traumatic moment with specially trained psychotherapists

Mental disorders are rising while the development of new psychiatric medications is declining. This has led some therapists and researchers to return to psychedelic-assisted psychotherapy (PAP), according to neuroscientist Eduardo Eckman Schenberg. Schenberg has conducted his own research and is involved with the design of clinical trials with psychedelics in Brazil.


The PAP model typically involves the therapeutic use of a potent psychoactive substance in a few sessions. These are generally accompanied by drug-free sessions before and/or after drug sessions (preparatory and integrative psychotherapy). Combining psychotherapy with psychedelics can be thought of as introducing an experience with positive long-term mental health consequences, rather than daily neurochemical corrections in brain dysfunctions. Instead of conceiving the drug as correcting functional imbalances in the brain through a specific receptor, specific pharmacological actions temporarily induce modifications in brain functioning and conscious experience.


MethylenodioxyMetamphetamine (MDMA) inhibits monoamine transporters, especially for serotonin, boosts chemicals such as serotonin and oxytocin and tamps down activity in the amygdala, a part of the brain that processes fear. MDMA has been studied for post-traumatic stress disorder (PTSD), social anxiety in autistic adults, existential anxiety and alcohol use disorder. MDMA is not the same